craft-sa-dev Home  

PMC:1189073 / 31777-32191 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T15515 0-3 NN denotes ENU
T15517 4-15 VBN denotes mutagenized
T15518 16-21 NN denotes C57BL
T15519 21-22 HYPH denotes /
T15520 22-23 CD denotes 6
T15516 24-28 NNS denotes mice
T15522 29-33 VBD denotes were
T15521 34-43 VBN denotes generated
T15523 44-46 IN denotes as
T15524 47-56 VBN denotes described
T15525 57-58 -LRB- denotes [
T15526 58-60 CD denotes 19
T15527 60-61 -RRB- denotes ]
T15528 61-62 . denotes .
T15529 62-278 sentence denotes Mice were maintained by backcrossing affected animals to C57BL/6 and housed in the Genomics Institute of the Novartis Research Foundation Specific Pathogen Free animal facility (La Jolla, California, United States).
T15530 63-67 NNS denotes Mice
T15532 68-72 VBD denotes were
T15531 73-83 VBN denotes maintained
T15533 84-86 IN denotes by
T15534 87-99 VBG denotes backcrossing
T15535 100-108 VBN denotes affected
T15536 109-116 NNS denotes animals
T15537 117-119 IN denotes to
T15538 120-125 NN denotes C57BL
T15539 125-126 HYPH denotes /
T15540 126-127 CD denotes 6
T15541 128-131 CC denotes and
T15542 132-138 VBN denotes housed
T15543 139-141 IN denotes in
T15544 142-145 DT denotes the
T15546 146-154 NNP denotes Genomics
T15545 155-164 NNP denotes Institute
T15547 165-167 IN denotes of
T15548 168-171 DT denotes the
T15550 172-180 NNP denotes Novartis
T15552 181-189 NNP denotes Research
T15551 190-200 NNP denotes Foundation
T15553 201-209 NNP denotes Specific
T15554 210-218 NNP denotes Pathogen
T15555 219-223 NNP denotes Free
T15556 224-230 NNP denotes animal
T15549 231-239 NNP denotes facility
T15557 240-241 -LRB- denotes (
T15559 241-243 NNP denotes La
T15558 244-249 NNP denotes Jolla
T15560 249-251 , denotes ,
T15561 251-261 NNP denotes California
T15562 261-263 , denotes ,
T15563 263-269 NNP denotes United
T15564 270-276 NNP denotes States
T15565 276-277 -RRB- denotes )
T15566 277-278 . denotes .
T15567 278-414 sentence denotes All procedures were approved by the Genomics Institute of the Novartis Research Foundation Institutional Animal Care and Use Committee.
T15568 279-282 DT denotes All
T15569 283-293 NNS denotes procedures
T15571 294-298 VBD denotes were
T15570 299-307 VBN denotes approved
T15572 308-310 IN denotes by
T15573 311-314 DT denotes the
T15575 315-323 NNP denotes Genomics
T15574 324-333 NNP denotes Institute
T15576 334-336 IN denotes of
T15577 337-340 DT denotes the
T15579 341-349 NNP denotes Novartis
T15581 350-358 NNP denotes Research
T15580 359-369 NNP denotes Foundation
T15582 370-383 NNP denotes Institutional
T15583 384-390 NNP denotes Animal
T15584 391-395 NNP denotes Care
T15585 396-399 CC denotes and
T15586 400-403 NNP denotes Use
T15578 404-413 NNP denotes Committee
T15587 413-414 . denotes .
R4480 T15515 T15516 nmod ENU,mice
R4481 T15516 T15521 nsubjpass mice,generated
R4482 T15517 T15516 amod mutagenized,mice
R4483 T15518 T15516 nmod C57BL,mice
R4484 T15519 T15518 punct /,C57BL
R4485 T15520 T15518 nummod 6,C57BL
R4486 T15522 T15521 auxpass were,generated
R4487 T15523 T15524 mark as,described
R4488 T15524 T15521 advcl described,generated
R4489 T15525 T15526 punct [,19
R4490 T15526 T15521 parataxis 19,generated
R4491 T15527 T15526 punct ],19
R4492 T15528 T15521 punct .,generated
R4493 T15530 T15531 nsubjpass Mice,maintained
R4494 T15532 T15531 auxpass were,maintained
R4495 T15533 T15531 prep by,maintained
R4496 T15534 T15533 pcomp backcrossing,by
R4497 T15535 T15536 amod affected,animals
R4498 T15536 T15534 dobj animals,backcrossing
R4499 T15537 T15534 prep to,backcrossing
R4500 T15538 T15537 pobj C57BL,to
R4501 T15539 T15538 punct /,C57BL
R4502 T15540 T15538 nummod 6,C57BL
R4503 T15541 T15531 cc and,maintained
R4504 T15542 T15531 conj housed,maintained
R4505 T15543 T15542 prep in,housed
R4506 T15544 T15545 det the,Institute
R4507 T15545 T15543 pobj Institute,in
R4508 T15546 T15545 compound Genomics,Institute
R4509 T15547 T15545 prep of,Institute
R4510 T15548 T15549 det the,facility
R4511 T15549 T15547 pobj facility,of
R4512 T15550 T15551 compound Novartis,Foundation
R4513 T15551 T15549 compound Foundation,facility
R4514 T15552 T15551 compound Research,Foundation
R4515 T15553 T15554 compound Specific,Pathogen
R4516 T15554 T15555 compound Pathogen,Free
R4517 T15555 T15549 compound Free,facility
R4518 T15556 T15549 compound animal,facility
R4519 T15557 T15558 punct (,Jolla
R4520 T15558 T15549 parataxis Jolla,facility
R4521 T15559 T15558 compound La,Jolla
R4522 T15560 T15558 punct ", ",Jolla
R4523 T15561 T15558 npadvmod California,Jolla
R4524 T15562 T15558 punct ", ",Jolla
R4525 T15563 T15564 compound United,States
R4526 T15564 T15558 npadvmod States,Jolla
R4527 T15565 T15558 punct ),Jolla
R4528 T15566 T15531 punct .,maintained
R4529 T15568 T15569 det All,procedures
R4530 T15569 T15570 nsubjpass procedures,approved
R4531 T15571 T15570 auxpass were,approved
R4532 T15572 T15570 agent by,approved
R4533 T15573 T15574 det the,Institute
R4534 T15574 T15572 pobj Institute,by
R4535 T15575 T15574 compound Genomics,Institute
R4536 T15576 T15574 prep of,Institute
R4537 T15577 T15578 det the,Committee
R4538 T15578 T15576 pobj Committee,of
R4539 T15579 T15580 nmod Novartis,Foundation
R4540 T15580 T15578 nmod Foundation,Committee
R4541 T15581 T15580 nmod Research,Foundation
R4542 T15582 T15583 nmod Institutional,Animal
R4543 T15583 T15578 nmod Animal,Committee
R4544 T15584 T15583 appos Care,Animal
R4545 T15585 T15584 cc and,Care
R4546 T15586 T15584 conj Use,Care
R4547 T15587 T15570 punct .,approved